S&P 500   4,593.46 (+0.56%)
DOW   36,237.26 (+0.80%)
QQQ   389.79 (+0.25%)
AAPL   191.28 (+0.70%)
MSFT   374.74 (-1.10%)
META   325.14 (-0.61%)
GOOGL   131.71 (-0.62%)
AMZN   146.92 (+0.57%)
TSLA   237.69 (-1.00%)
NVDA   467.25 (-0.10%)
NIO   7.19 (-1.10%)
BABA   73.82 (-1.42%)
AMD   121.07 (-0.07%)
T   16.70 (+0.78%)
F   10.55 (+2.83%)
MU   75.85 (-0.35%)
CGC   0.62 (+11.46%)
GE   122.98 (+0.97%)
DIS   92.38 (-0.33%)
AMC   6.88 (+3.46%)
PFE   28.90 (-5.15%)
PYPL   59.67 (+3.58%)
XOM   102.73 (+-0.01%)
S&P 500   4,593.46 (+0.56%)
DOW   36,237.26 (+0.80%)
QQQ   389.79 (+0.25%)
AAPL   191.28 (+0.70%)
MSFT   374.74 (-1.10%)
META   325.14 (-0.61%)
GOOGL   131.71 (-0.62%)
AMZN   146.92 (+0.57%)
TSLA   237.69 (-1.00%)
NVDA   467.25 (-0.10%)
NIO   7.19 (-1.10%)
BABA   73.82 (-1.42%)
AMD   121.07 (-0.07%)
T   16.70 (+0.78%)
F   10.55 (+2.83%)
MU   75.85 (-0.35%)
CGC   0.62 (+11.46%)
GE   122.98 (+0.97%)
DIS   92.38 (-0.33%)
AMC   6.88 (+3.46%)
PFE   28.90 (-5.15%)
PYPL   59.67 (+3.58%)
XOM   102.73 (+-0.01%)
S&P 500   4,593.46 (+0.56%)
DOW   36,237.26 (+0.80%)
QQQ   389.79 (+0.25%)
AAPL   191.28 (+0.70%)
MSFT   374.74 (-1.10%)
META   325.14 (-0.61%)
GOOGL   131.71 (-0.62%)
AMZN   146.92 (+0.57%)
TSLA   237.69 (-1.00%)
NVDA   467.25 (-0.10%)
NIO   7.19 (-1.10%)
BABA   73.82 (-1.42%)
AMD   121.07 (-0.07%)
T   16.70 (+0.78%)
F   10.55 (+2.83%)
MU   75.85 (-0.35%)
CGC   0.62 (+11.46%)
GE   122.98 (+0.97%)
DIS   92.38 (-0.33%)
AMC   6.88 (+3.46%)
PFE   28.90 (-5.15%)
PYPL   59.67 (+3.58%)
XOM   102.73 (+-0.01%)
S&P 500   4,593.46 (+0.56%)
DOW   36,237.26 (+0.80%)
QQQ   389.79 (+0.25%)
AAPL   191.28 (+0.70%)
MSFT   374.74 (-1.10%)
META   325.14 (-0.61%)
GOOGL   131.71 (-0.62%)
AMZN   146.92 (+0.57%)
TSLA   237.69 (-1.00%)
NVDA   467.25 (-0.10%)
NIO   7.19 (-1.10%)
BABA   73.82 (-1.42%)
AMD   121.07 (-0.07%)
T   16.70 (+0.78%)
F   10.55 (+2.83%)
MU   75.85 (-0.35%)
CGC   0.62 (+11.46%)
GE   122.98 (+0.97%)
DIS   92.38 (-0.33%)
AMC   6.88 (+3.46%)
PFE   28.90 (-5.15%)
PYPL   59.67 (+3.58%)
XOM   102.73 (+-0.01%)

P3 Health Partners Stock Price, News & Analysis (NASDAQ:PIII)

$1.16
-0.04 (-2.92%)
(As of 02:40 PM ET)
Compare
Today's Range
$1.13
$1.20
50-Day Range
$1.14
$1.90
52-Week Range
$0.70
$5.56
Volume
175,563 shs
Average Volume
425,436 shs
Market Capitalization
$364.75 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00

P3 Health Partners MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
338.6% Upside
$5.00 Price Target
Short Interest
Bearish
7.20% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
$1 M Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.98) to ($0.54) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.97 out of 5 stars

Medical Sector

640th out of 949 stocks

Health Services Industry

6th out of 12 stocks


PIII stock logo

About P3 Health Partners Stock (NASDAQ:PIII)

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.

PIII Stock Price History

PIII Stock News Headlines

Is Gold Really Boring?
Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.
55,508
P3 Health Partners Inc - Ordinary Shares - Class A
Is Gold Really Boring?
Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.
P3 Health Partners Recent Insider Activity
Massive Insider Trade At P3 Health Partners
BTIG Keeps Their Buy Rating on P3 Health Partners (PIII)
P3 Health Partners On Solid Path To Profitability
See More Headlines
Receive PIII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for P3 Health Partners and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/08/2023
Today
12/01/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
3/29/2024

Industry, Sector and Symbol

Industry
Health services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PIII
Fax
N/A
Employees
600
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.00
High Stock Price Target
$5.00
Low Stock Price Target
$5.00
Potential Upside/Downside
+316.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$-270,130,000.00
Pretax Margin
-54.92%

Debt

Sales & Book Value

Annual Sales
$1.18 billion
Cash Flow
$40.00 per share
Book Value
$0.60 per share

Miscellaneous

Free Float
259,676,000
Market Cap
$375.71 million
Optionable
Not Optionable
Beta
1.39
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Dr. Sherif Abdou F.A.C.E.P. (Age 62)
    FACP, M.D., Co-Founder, CEO & Director
    Comp: $7.1M
  • Dr. Amir Bacchus M.B.A. (Age 58)
    M.D., Co-Founder, Chief Medical Officer & Director
    Comp: $4.3M
  • Mr. Atul Kavthekar
    CFO & Chief Accounting Officer
  • Mr. William Bettermann
    Executive VP & COO
  • Mr. Devery Goodey
    Senior Vice President of Technology
  • Ms. Karen Blomquist
    Vice President of Investor Relations
  • Ms. Jessica Puathasnanon
    Chief Legal Officer, General Counsel & Secretary
  • Roy Youngblood
    Director of Compliance
  • Ms. Kassi Belz APR
    Executive Vice President of Communications, Culture & Engagement
  • Ms. Lorie Glisson CPA
    Florida Market President














PIII Stock Analysis - Frequently Asked Questions

Should I buy or sell P3 Health Partners stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for P3 Health Partners in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" PIII shares.
View PIII analyst ratings
or view top-rated stocks.

What is P3 Health Partners' stock price target for 2024?

2 Wall Street research analysts have issued twelve-month target prices for P3 Health Partners' shares. Their PIII share price targets range from $5.00 to $5.00. On average, they anticipate the company's stock price to reach $5.00 in the next year. This suggests a possible upside of 338.6% from the stock's current price.
View analysts price targets for PIII
or view top-rated stocks among Wall Street analysts.

How have PIII shares performed in 2023?

P3 Health Partners' stock was trading at $1.84 on January 1st, 2023. Since then, PIII stock has decreased by 38.0% and is now trading at $1.14.
View the best growth stocks for 2023 here
.

When is P3 Health Partners' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, March 29th 2024.
View our PIII earnings forecast
.

How were P3 Health Partners' earnings last quarter?

P3 Health Partners Inc. (NASDAQ:PIII) announced its quarterly earnings results on Wednesday, November, 8th. The company reported ($0.12) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.23) by $0.11. The firm earned $288.35 million during the quarter, compared to analysts' expectations of $286 million. P3 Health Partners had a negative net margin of 10.73% and a positive trailing twelve-month return on equity of 2,454.69%.

Who are P3 Health Partners' major shareholders?

P3 Health Partners' stock is owned by many different retail and institutional investors. Top institutional shareholders include Ameriprise Financial Inc. (1.74%), FMR LLC (0.76%), Emfo LLC (0.32%), GSA Capital Partners LLP (0.03%), Principal Financial Group Inc. (0.03%) and PNC Financial Services Group Inc. (0.02%). Insiders that own company stock include Atul Kavthekar, Michael Balkin, Pacific Founders Ugp Chicago, Pacific Founders Ugp I Chicago and Sherif Abdou.
View institutional ownership trends
.

How do I buy shares of P3 Health Partners?

Shares of PIII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:PIII) was last updated on 12/1/2023 by MarketBeat.com Staff

My Account -